# agilon health (AGL) — Analyst Forecast

AGL · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/agl/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 5 | 9 | 1 | 15 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $85.00 | $119.88 | $146.00 | 8 |

Last price $88.45 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 15, 2026 | Bernstein | Upgraded | Market Perform → Outperform | $125.00 |
| Aug 24, 2026 | JP Morgan | Maintained | Underweight | $85.00 |
| Aug 11, 2026 | Citigroup | Upgraded | Sell → Neutral | $115.00 |
| Aug 11, 2026 | Wells Fargo | Maintained | Overweight | $146.00 |
| Aug 6, 2026 | Barclays | Maintained | Equal-Weight | $111.00 |
| Aug 6, 2026 | Evercore ISI Group | Maintained | In-Line | $125.00 |
| Aug 6, 2026 | Benchmark | Maintained | Buy | $140.00 |
| Aug 6, 2026 | Truist Securities | Maintained | Hold | $112.00 |
| Jul 23, 2026 | Citigroup | Downgraded | Neutral → Sell | $105.00 |
| Jul 13, 2026 | Wells Fargo | Maintained | Overweight | $141.00 |
| May 26, 2026 | Barclays | Upgraded | Underweight → Equal-Weight | $81.00 |
| May 21, 2026 | Benchmark | Maintained | Buy | $95.00 |
| May 15, 2026 | Citigroup | Maintained | Neutral | $80.00 |
| May 11, 2026 | TD Cowen | Maintained | Hold | $55.00 |
| May 8, 2026 | Wells Fargo | Maintained | Overweight | $72.00 |
| May 7, 2026 | Deutsche Bank | Upgraded | Hold → Buy | $49.00 |
| May 7, 2026 | Baird | Maintained | Neutral | $35.00 |
| May 7, 2026 | Jefferies | Upgraded | Hold → Buy | $48.00 |
| May 7, 2026 | Evercore ISI Group | Maintained | In-Line | $32.00 |
| May 4, 2026 | JP Morgan | Downgraded | Neutral → Underweight | $21.00 |

## Frequently Asked Questions

### What is the price target for AGL stock?

The average 12-month analyst price target for agilon health (AGL) is $119.88, with a high estimate of $146.00 and a low of $85.00, across 8 analysts.

### Is AGL a buy, sell, or hold?

Analysts covering agilon health currently average a Hold rating: 5 buy, 9 hold and 1 sell, from 15 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for AGL?

The average price target of $119.88 implies 35.53% upside from the last price of $88.45.

### What is the latest analyst rating on AGL?

On Sep 15, 2026, Bernstein upgraded agilon health to Outperform with a price target of $125.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).